Berkshire Hathaway Inc (BRK-A)vsDrugs Made In America Acquisition Corp. Ordinary Shares (DMAA)
BRK-A
Berkshire Hathaway Inc
$761,579.98
+2.11%
FINANCIAL SERVICES · Cap: $1.07T
DMAA
Drugs Made In America Acquisition Corp. Ordinary Shares
$10.66
0.00%
FINANCIAL SERVICES · Cap: $258.06M
Smart Verdict
WallStSmart Research — data-driven comparison
BRK-A leads profitability with a 19.3% profit margin vs 0.0%. BRK-A trades at a lower P/E of 14.8x. BRK-A earns a higher WallStSmart Score of 61/100 (C+).
BRK-A
Buy61
out of 100
Grade: C+
DMAA
Avoid34
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Earnings expanding 119.6% YoY
Conservative balance sheet, low leverage
Attractively priced relative to earnings
Reasonable price relative to book value
Generating 5.5B in free cash flow
Conservative balance sheet, low leverage
Areas to Watch
4.4% revenue growth
Expensive relative to growth rate
0.0% revenue growth
Smaller company, higher risk/reward
ROE of 2.8% — below average capital efficiency
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : BRK-A
The strongest argument for BRK-A centers on Market Cap, EPS Growth, Debt/Equity. Profitability is solid with margins at 19.3% and operating margin at 14.3%.
Bull Case : DMAA
The strongest argument for DMAA centers on Debt/Equity.
Bear Case : BRK-A
The primary concerns for BRK-A are Revenue Growth, PEG Ratio.
Bear Case : DMAA
The primary concerns for DMAA are Revenue Growth, Market Cap, Return on Equity. A P/E of 53.1x leaves little room for execution misses.
Key Dynamics to Monitor
BRK-A is growing revenue faster at 4.4% — sustainability is the question.
BRK-A generates stronger free cash flow (5.5B), providing more financial flexibility.
Monitor INSURANCE - DIVERSIFIED industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BRK-A scores higher overall (61/100 vs 34/100), backed by strong 19.3% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Berkshire Hathaway Inc
FINANCIAL SERVICES · INSURANCE - DIVERSIFIED · USA
Berkshire Hathaway Inc. is an American multinational conglomerate holding company headquartered in Omaha, Nebraska, United States. The company wholly owns GEICO, Duracell, Dairy Queen, BNSF, Lubrizol, Fruit of the Loom, Helzberg Diamonds, Long & Foster, FlightSafety International, Pampered Chef, Forest River, and NetJets, and also owns 38.6% of Pilot Flying J; and significant minority holdings in public companies Kraft Heinz Company (26.7%), American Express (18.8%), The Coca-Cola Company (9.32%), Bank of America (11.9%), and Apple (6.3%).
Visit Website →Drugs Made In America Acquisition Corp. Ordinary Shares
FINANCIAL SERVICES · SHELL COMPANIES · USA
Drugs Made In America Acquisition Corp. (DMAA) is a special purpose acquisition company aimed at transforming the U.S. pharmaceutical industry by fostering strategic partnerships with innovative healthcare enterprises. With a commitment to enhancing domestic drug production and addressing critical supply chain vulnerabilities, DMAA seeks to ensure the availability of affordable medications for consumers. By leveraging cutting-edge technologies and promoting local manufacturing initiatives, DMAA is well-positioned to play a pivotal role in reshaping the landscape of pharmaceutical access in the United States.
Compare with Other INSURANCE - DIVERSIFIED Stocks
Want to dig deeper into these stocks?